İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2012 · article

Primer Açık Açılı Glokomlu Hastalarda Latanoprost 0 005 Timolol Maleat 0 5 ile Dorzolamid 2 Timolol Maleat 0 5 Sabit Kombinasyonlarının 24 Saatlik Göz İçi Basıncına Etkileri

Dergi Turkish Journal of Ophthalmology
YÖKSİS OpenAlex Açık erişim · diamond
Yıl2012
Atıf2OpenAlex
Yüzdelik%65,8
FWCI0,281,00 = dünya ortalaması
Scopus (SJR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTurkish Journal of Ophthalmology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex Türkçe

Pur po se: To evaluate the effects of latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations on-24 hours intraocular pressure in patients with open-angle glaucoma. Ma te ri als and Met hod: Forty-eight eyes of 24 patients with open-angle glaucoma were enrolled in the study. They were randomized to receive fixed combinations of either latanoprost/timolol maleate (Group 1 - 24 eyes of 12 patients) or dorzolamid/timolol maleate (Group 2 - 24 eyes of 12 patients). Patients who achieved intraocular pressure of ≤ 21 mmHg 3 weeks after combined therapy were hospitalized and intraocular pressure was monitored at hour 06:00, 10:00, 14:00, 18:00, 22:00 and 02:00 for 24 hours. Diurnal and nocturnal fluctuations were determined by measurements done between 06:00 and 18:00 hours and between 22:00 and 02:00, respectively. Mean intraocular pressure and fluctuations of intraocular pressure between the two groups were compared. Re sults: There was no difference between the groups in terms of age, sex, visual acuity and cup/disc ratio (p>0.05). Three weeks after combined therapy, all patients achieved target intraocular pressure of ≤ 21 mmHg. There was no statistically significant difference between the two groups with regard to mean intraocular pressure over 24 hours (17.1±2.3 mmHg and 17.27±2.3 mmHg for Group 1 and Group 2, respectively; p>0.05). Diurnal fluctuations were 3.6 mmHg for Group 1 and 4.7 mmHg for Group 2; nocturnal fluctuations were 4.3 mmHg for Group 1 and 2.3 mmHg for Group 2. Diurnal fluctuations in Group 1 were lower than in Group 2, while nocturnal fluctuations were lower in Group 2 than in Group 1 (p<0.05). Dis cus si on: Both latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations are effective for 24-hour intraocular pressure control. Latanoprost/timolol maleate fixed combination is superior to dorzolamid/timolol maleate in controlling diurnal fluctuations, while dorzolamid/timolol maleate is better in controlling nocturnal fluctuations. (Turk J Ophthalmol 2012; 42: 5-10)

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

2atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 5 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2021 Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edemaAtıf 6 · OpenAlex
  2. 2021 Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edemaAtıf 6 · OpenAlex
  3. 2021 Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edemaAtıf 6 · OpenAlex
  4. 2021 Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edemaAtıf 6 · OpenAlex
  5. 2021 Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edemaAtıf 5 · OpenAlex

Yazarlar

4
  1. BERNA YÜCE 1
  2. SUZAN GÜVEN EGE ÜNİVERSİTESİ 2
  3. KUTAY ANDAÇ 3
  4. HALİL ATEŞ 4